View in EDS HTML Full Text PDF Full Text

MGST1 drives lymph node metastasis in papillary thyroid carcinoma via mitochondrial metabolic reprogramming and immune suppression.

Saved in:
Bibliographic Details
Title: MGST1 drives lymph node metastasis in papillary thyroid carcinoma via mitochondrial metabolic reprogramming and immune suppression.
Authors: Wang QX; Department of Thyroid Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.; Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, First Affiliated Hospital, Wenzhou Medical University, Wenzhou, China., Yu CF; School of Ophthalmology & Optometry, Wenzhou Medical University, Wenzhou, Zhejiang, China., Zhang KC; The First Clinical Medical College, Wenzhou Medical University, Wenzhou, Zhejiang, China., Zhang JH; The First Clinical Medical College, Wenzhou Medical University, Wenzhou, Zhejiang, China., Zhou XJ; The First Clinical Medical College, Wenzhou Medical University, Wenzhou, Zhejiang, China., Zou TX; The First Clinical Medical College, Wenzhou Medical University, Wenzhou, Zhejiang, China., Huang HZ; The First Clinical Medical College, Wenzhou Medical University, Wenzhou, Zhejiang, China., Han TY; The First Clinical Medical College, Wenzhou Medical University, Wenzhou, Zhejiang, China., Mei HZ; The First Clinical Medical College, Wenzhou Medical University, Wenzhou, Zhejiang, China., Su KB; The First Clinical Medical College, Wenzhou Medical University, Wenzhou, Zhejiang, China., You J; Department of Thyroid Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.; Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, First Affiliated Hospital, Wenzhou Medical University, Wenzhou, China., Qu JM; Department of Thyroid Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.; Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, First Affiliated Hospital, Wenzhou Medical University, Wenzhou, China., Xie C; Department of General Surgery, Zhejiang Dinghai Hospital, Shanghai Ruijin Hospital Zhoushan Branch, Zhoushan, Zhejiang, China., Li Q; Department of Breast Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China., Cai YF; Department of Thyroid Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.; Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, First Affiliated Hospital, Wenzhou Medical University, Wenzhou, China.
Source: Frontiers in immunology [Front Immunol] 2026 Jun 04; Vol. 17, pp. 1848083. Date of Electronic Publication: 2026 Jun 04 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42327722
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: MGST1 drives lymph node metastasis in papillary thyroid carcinoma via mitochondrial metabolic reprogramming and immune suppression.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Wang+QX%22">Wang QX</searchLink>; Department of Thyroid Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.; Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, First Affiliated Hospital, Wenzhou Medical University, Wenzhou, China.<br /><searchLink fieldCode="AU" term="%22Yu+CF%22">Yu CF</searchLink>; School of Ophthalmology & Optometry, Wenzhou Medical University, Wenzhou, Zhejiang, China.<br /><searchLink fieldCode="AU" term="%22Zhang+KC%22">Zhang KC</searchLink>; The First Clinical Medical College, Wenzhou Medical University, Wenzhou, Zhejiang, China.<br /><searchLink fieldCode="AU" term="%22Zhang+JH%22">Zhang JH</searchLink>; The First Clinical Medical College, Wenzhou Medical University, Wenzhou, Zhejiang, China.<br /><searchLink fieldCode="AU" term="%22Zhou+XJ%22">Zhou XJ</searchLink>; The First Clinical Medical College, Wenzhou Medical University, Wenzhou, Zhejiang, China.<br /><searchLink fieldCode="AU" term="%22Zou+TX%22">Zou TX</searchLink>; The First Clinical Medical College, Wenzhou Medical University, Wenzhou, Zhejiang, China.<br /><searchLink fieldCode="AU" term="%22Huang+HZ%22">Huang HZ</searchLink>; The First Clinical Medical College, Wenzhou Medical University, Wenzhou, Zhejiang, China.<br /><searchLink fieldCode="AU" term="%22Han+TY%22">Han TY</searchLink>; The First Clinical Medical College, Wenzhou Medical University, Wenzhou, Zhejiang, China.<br /><searchLink fieldCode="AU" term="%22Mei+HZ%22">Mei HZ</searchLink>; The First Clinical Medical College, Wenzhou Medical University, Wenzhou, Zhejiang, China.<br /><searchLink fieldCode="AU" term="%22Su+KB%22">Su KB</searchLink>; The First Clinical Medical College, Wenzhou Medical University, Wenzhou, Zhejiang, China.<br /><searchLink fieldCode="AU" term="%22You+J%22">You J</searchLink>; Department of Thyroid Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.; Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, First Affiliated Hospital, Wenzhou Medical University, Wenzhou, China.<br /><searchLink fieldCode="AU" term="%22Qu+JM%22">Qu JM</searchLink>; Department of Thyroid Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.; Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, First Affiliated Hospital, Wenzhou Medical University, Wenzhou, China.<br /><searchLink fieldCode="AU" term="%22Xie+C%22">Xie C</searchLink>; Department of General Surgery, Zhejiang Dinghai Hospital, Shanghai Ruijin Hospital Zhoushan Branch, Zhoushan, Zhejiang, China.<br /><searchLink fieldCode="AU" term="%22Li+Q%22">Li Q</searchLink>; Department of Breast Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.<br /><searchLink fieldCode="AU" term="%22Cai+YF%22">Cai YF</searchLink>; Department of Thyroid Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.; Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, First Affiliated Hospital, Wenzhou Medical University, Wenzhou, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2026 Jun 04; Vol. 17, pp. 1848083. <i>Date of Electronic Publication: </i>2026 Jun 04 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42327722
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2026.1848083
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1848083
    Titles:
      – TitleFull: MGST1 drives lymph node metastasis in papillary thyroid carcinoma via mitochondrial metabolic reprogramming and immune suppression.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wang QX
      – PersonEntity:
          Name:
            NameFull: Yu CF
      – PersonEntity:
          Name:
            NameFull: Zhang KC
      – PersonEntity:
          Name:
            NameFull: Zhang JH
      – PersonEntity:
          Name:
            NameFull: Zhou XJ
      – PersonEntity:
          Name:
            NameFull: Zou TX
      – PersonEntity:
          Name:
            NameFull: Huang HZ
      – PersonEntity:
          Name:
            NameFull: Han TY
      – PersonEntity:
          Name:
            NameFull: Mei HZ
      – PersonEntity:
          Name:
            NameFull: Su KB
      – PersonEntity:
          Name:
            NameFull: You J
      – PersonEntity:
          Name:
            NameFull: Qu JM
      – PersonEntity:
          Name:
            NameFull: Xie C
      – PersonEntity:
          Name:
            NameFull: Li Q
      – PersonEntity:
          Name:
            NameFull: Cai YF
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 04
              M: 06
              Text: 2026 Jun 04
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 17
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1